22 Jan Umoja Biopharma
Posted at 21:24h
in
David Fontana, Ph.D., Chief Operations Officer and Chief Business Officer
April 15 | 4:30pm | Salone dei Cavalieri, Section 2
Seattle, WA
(Private)
Private biotech focused on bringing the transformational activity of CAR T therapy to all patients in need. We are the leaders in in vivo cart delivery with two products in the clinic, our own GMP manufacturing facility and strong Pharma partnerships. Umoja also has an iPSC platform and a targeting approach for solid tumors in development. We are committed to share our learning along the development path with the ARM membership
